06 Oct 2021
Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients
Sponsored by Biosensors
Summary
In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using one-month DAPT, among them the largest one: MASTER-DAPT.